Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,027 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R, Higashida R, Marr A, Nguyen TN, Roux S, Smrčka M, Torné RT, Aldrich EF; on behalf of the REACT investigators. Mayer SA, et al. Among authors: dubois c. J Neurosurg. 2024 Aug 9:1-12. doi: 10.3171/2024.4.JNS232191. Online ahead of print. J Neurosurg. 2024. PMID: 39126720
The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Bruder N, Higashida R, Santin-Janin H, Dubois C, Aldrich EF, Marr A, Roux S, Mayer SA. Bruder N, et al. Among authors: dubois c. BMC Neurol. 2022 Dec 20;22(1):492. doi: 10.1186/s12883-022-03002-8. BMC Neurol. 2022. PMID: 36539711 Free PMC article. Clinical Trial.
Survivin promotes stem cell competence for skin cancer initiation.
Canato S, Sarate R, Carvalho-Marques S, Maia Soares R, Song Y, Monteiro-Ferreira S, Vieugué P, Liagre M, Grossi G, Cardoso E, Dubois C, Conway EM, Schenone S, Sanchez-Danes A, Blanpain C. Canato S, et al. Among authors: dubois c. Cancer Discov. 2024 Nov 11. doi: 10.1158/2159-8290.CD-24-0263. Online ahead of print. Cancer Discov. 2024. PMID: 39526566
Coronary Physiological Indices to Evaluate Myocardial Ischemia in Patients with Aortic Stenosis Undergoing Valve Replacement.
Minten L, McCutcheon K, Vanhaverbeke M, Wouters L, Bézy S, Lesizza P, Jentjens S, Frederiks P, Bringmans T, Voigt JU, Adriaenssens T, Desmet W, Sinnaeve P, Jacobs S, Verbrugghe P, Meuris B, Janssens S, Fearon WF, Bennett J, Dubois C. Minten L, et al. Among authors: dubois c. JACC Cardiovasc Interv. 2024 Oct 18:S1936-8798(24)01421-3. doi: 10.1016/j.jcin.2024.10.024. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 39474985
Musa species in mainland Southeast Asia: From wild to domesticate.
Jenny C, Sachter-Smith G, Breton C, Rivallan R, Jacquemoud-Collet JP, Dubois C, Chabannes M, Lý NS, Haevermans T, Triệu TD, Insisiengmay O, Zhang T, Caruana ML, Sardos J, Perrier X. Jenny C, et al. Among authors: dubois c. PLoS One. 2024 Oct 2;19(10):e0307592. doi: 10.1371/journal.pone.0307592. eCollection 2024. PLoS One. 2024. PMID: 39356650 Free PMC article.
Targeting BTN2A1 enhances Vγ9Vδ2 T-cell effector functions and triggers tumor cell pyroptosis.
Le Floch AC, Imbert C, Boucherit N, Gorvel L, Fattori S, Orlanducci F, Le Roy A, Archetti L, Crescence L, Panicot-Dubois L, Dubois C, Vey N, Briantais A, Anastasio A, Cano C, Guittard G, Frechin M, Olive D. Le Floch AC, et al. Among authors: dubois c. Cancer Immunol Res. 2024 Sep 20. doi: 10.1158/2326-6066.CIR-23-0868. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39302336
1,027 results